P1110: REAL-WORLD TREATMENT PATTERNS OF BRUTON TYROSINE KINASE INHIBITORS (BTKI) IN PATIENTS WITH MANTLE CELL LYMPHOMA (MCL) IN COMMUNITY ONCOLOGY PRACTICES IN THE UNITED STATES (US)
Bijal Shah,
Mei Xue,
Keri Yang,
Sizhu (Tom) Liu,
Boxiong Tang
Affiliations
Bijal Shah
1 Moffitt Cancer Center, Tampa, United States
Mei Xue
2 BeiGene USA, Inc., San Mateo, United States
Keri Yang
2 BeiGene USA, Inc., San Mateo, United States
Sizhu (Tom) Liu
3 Formerly with BeiGene USA, Inc., San Mateo, United States
